Treatment of leukemia

The proportion of young people suffering from acute leukemia is large, but it is not absolute. At present, the proportion of young people suffering from chronic myeloid leukemia is also quite high. In addition, there are many kinds of acute leukemia (acute leukemia and acute non-leukemia), and the treatment methods are different according to some physical indexes of patients, so not all leukemia need bone marrow transplantation.

The specific treatment needs to be decided by the following aspects:

First, the younger the patient, the better.

FAB classification of leukemia: acute lymphocytic L 1~L3, acute nonlymphocytic M0~M7, chronic leukemia, special leukemia.

3. Chromosome examination Karyotype changes determine the cure rate and means.

Fourth, the patient's condition at admission and treatment, the number of platelets and white blood cells affect the prognosis.

The more sensitive leukemia cells are to chemotherapy, the better.

Generally speaking, FAB typing has the greatest influence, and different typing largely determines the cure rate and treatment cycle.

For example, the cure rate of leukemia patients with AML M3 and chromosome t( 15, 17) changes can exceed 95%. Chemotherapy supplemented by traditional Chinese medicine does not require bone marrow transplantation.

However, chemotherapy is necessary for most leukemia patients, and a considerable number of patients recover under the treatment of combined chemotherapy. Even if bone marrow transplantation is needed, it should be done in a state of complete remission after chemotherapy.

Then talk about bone marrow transplantation: not all leukemia needs bone marrow transplantation. Doctors will weigh the risks in treatment and avoid bone marrow suppression as much as possible. Bone marrow transplantation is a follow-up means to treat leukemia, and it will only be chosen if other treatments are of little significance. Bone marrow transplantation itself requires high cost and contains great risks. About 12% of bone marrow transplant patients will die during transplantation, and 50% of patients who successfully leave the library will also have a chance.